Coxsackie virus - Revision history

Rossdonaldson1 at 23:45, 31 May 2022

2022-05-31T23:45:21Z

← Revisión anterior		Revisión del 23:45 31 may 2022
Línea 4:		Línea 4:
	*Coxsackie A virus associated with [[herpangina]] and [[hand-foot-and-mouth disease]]		*Coxsackie A virus associated with [[herpangina]] and [[hand-foot-and-mouth disease]]
	*Coxsackie B virus associated with dilated [[cardiomyopathy]]		*Coxsackie B virus associated with dilated [[cardiomyopathy]]

			==Clinical Features==

	==Differential Diagnosis==		==Differential Diagnosis==
Línea 10:		Línea 12:

	==Evaluation==		==Evaluation==
			===Workup===
			**If unsure, see [[pediatric fever]]

			===Diagnosis===
	*Clinical diagnosis, based on history and physical examination		*Clinical diagnosis, based on history and physical examination
	**If unsure, see [[Pediatric Fever]]

	==Management==		==Management==
Línea 19:		Línea 24:
	*Some recommend Magic Mouthwash/oral lidocaine if not tolerating PO intake, although evidence suggests no better than placebo<ref>Hopper S. et al. Topical lidocaine to improve oral intake in children with painful infectious mouth ulcers: a blinded, randomized, placebo-controlled trial. Ann Emerg Med. 2014 Mar;63(3):292-9</ref>		*Some recommend Magic Mouthwash/oral lidocaine if not tolerating PO intake, although evidence suggests no better than placebo<ref>Hopper S. et al. Topical lidocaine to improve oral intake in children with painful infectious mouth ulcers: a blinded, randomized, placebo-controlled trial. Ann Emerg Med. 2014 Mar;63(3):292-9</ref>
	'''In infants, do NOT use oral lidocaine due to risk of lidocaine toxicity and FDA black box warning'''<ref>FDA recommends not using lidocaine to treat teething pain. http://www.fda.gov/Drugs/DrugSafety/ucm402240.htm</ref><ref>Curtis LA, Dolan TS, Seibert HE. Are one or two dangerous? Lidocaine and topical anesthetic exposures in children. J Emerg Med 2009;37:32-39</ref>		'''In infants, do NOT use oral lidocaine due to risk of lidocaine toxicity and FDA black box warning'''<ref>FDA recommends not using lidocaine to treat teething pain. http://www.fda.gov/Drugs/DrugSafety/ucm402240.htm</ref><ref>Curtis LA, Dolan TS, Seibert HE. Are one or two dangerous? Lidocaine and topical anesthetic exposures in children. J Emerg Med 2009;37:32-39</ref>

	==Disposition==		==Disposition==
	*Discharge with close outpatient followup to ensure adequate PO intake.		*Discharge with close outpatient followup to ensure adequate PO intake.
Línea 35:		Línea 41:

	[[Category:ID]]		[[Category:ID]]
			[[Category:Pediatrics]]

Rossdonaldson1 at 23:43, 31 May 2022

2022-05-31T23:43:47Z

← Revisión anterior		Revisión del 23:43 31 may 2022
Línea 1:		Línea 1:
	==Background<ref>Sobolewski B, Mittiga MR, Gonzalez del Rey JA. Pediatric conditions. In: Knoop KJ, Stack LB, Storrow AB, Thurman RJ, eds. The Atlas of Emergency Medicine. 4th ed. New York, NY: McGraw-Hill; 2016:(Ch) 14.</ref>==		==Background==
	*Spread via the fecal-oral route
	*Most common in the summer and fall

	*Spread via the fecal-oral route<ref>Sobolewski B, Mittiga MR, Gonzalez del Rey JA. Pediatric conditions. In: Knoop KJ, Stack LB, Storrow AB, Thurman RJ, eds. The Atlas of Emergency Medicine. 4th ed. New York, NY: McGraw-Hill; 2016:(Ch) 14.</ref>		*Spread via the fecal-oral route<ref>Sobolewski B, Mittiga MR, Gonzalez del Rey JA. Pediatric conditions. In: Knoop KJ, Stack LB, Storrow AB, Thurman RJ, eds. The Atlas of Emergency Medicine. 4th ed. New York, NY: McGraw-Hill; 2016:(Ch) 14.</ref>
	*Most common in the summer and fall		*Most common in the summer and fall<ref>Sobolewski B, Mittiga MR, Gonzalez del Rey JA. Pediatric conditions. In: Knoop KJ, Stack LB, Storrow AB, Thurman RJ, eds. The Atlas of Emergency Medicine. 4th ed. New York, NY: McGraw-Hill; 2016:(Ch) 14.</ref>
	*Coxsackie A virus associated with [[herpangina]] and [[hand-foot-and-mouth disease]]		*Coxsackie A virus associated with [[herpangina]] and [[hand-foot-and-mouth disease]]
	*Coxsackie B virus associated with dilated [[cardiomyopathy]]		*Coxsackie B virus associated with dilated [[cardiomyopathy]]

Josgood at 23:16, 19 May 2022

2022-05-19T23:16:54Z

← Revisión anterior		Revisión del 23:16 19 may 2022
Línea 1:		Línea 1:
	==Background== <ref>Sobolewski B, Mittiga MR, Gonzalez del Rey JA. Pediatric conditions. In: Knoop KJ, Stack LB, Storrow AB, Thurman RJ, eds. The Atlas of Emergency Medicine. 4th ed. New York, NY: McGraw-Hill; 2016:(Ch) 14.</ref>		==Background<ref>Sobolewski B, Mittiga MR, Gonzalez del Rey JA. Pediatric conditions. In: Knoop KJ, Stack LB, Storrow AB, Thurman RJ, eds. The Atlas of Emergency Medicine. 4th ed. New York, NY: McGraw-Hill; 2016:(Ch) 14.</ref>==
	*Spread via the fecal-oral route		*Spread via the fecal-oral route
	*Most common in the summer and fall		*Most common in the summer and fall

Elcatracho: /* Background */

2022-01-03T11:00:27Z

Background

← Revisión anterior		Revisión del 11:00 3 ene 2022
Línea 2:		Línea 2:
	*Spread via the fecal-oral route		*Spread via the fecal-oral route
	*Most common in the summer and fall		*Most common in the summer and fall

	~~==Background==~~

	*Spread via the fecal-oral route<ref>Sobolewski B, Mittiga MR, Gonzalez del Rey JA. Pediatric conditions. In: Knoop KJ, Stack LB, Storrow AB, Thurman RJ, eds. The Atlas of Emergency Medicine. 4th ed. New York, NY: McGraw-Hill; 2016:(Ch) 14.</ref>		*Spread via the fecal-oral route<ref>Sobolewski B, Mittiga MR, Gonzalez del Rey JA. Pediatric conditions. In: Knoop KJ, Stack LB, Storrow AB, Thurman RJ, eds. The Atlas of Emergency Medicine. 4th ed. New York, NY: McGraw-Hill; 2016:(Ch) 14.</ref>

Elcatracho: /* Background */

2022-01-03T10:59:55Z

Background

← Revisión anterior		Revisión del 10:59 3 ene 2022
Línea 4:		Línea 4:

	==Background==		==Background==

	*Spread via the fecal-oral route<ref>Sobolewski B, Mittiga MR, Gonzalez del Rey JA. Pediatric conditions. In: Knoop KJ, Stack LB, Storrow AB, Thurman RJ, eds. The Atlas of Emergency Medicine. 4th ed. New York, NY: McGraw-Hill; 2016:(Ch) 14.</ref>		*Spread via the fecal-oral route<ref>Sobolewski B, Mittiga MR, Gonzalez del Rey JA. Pediatric conditions. In: Knoop KJ, Stack LB, Storrow AB, Thurman RJ, eds. The Atlas of Emergency Medicine. 4th ed. New York, NY: McGraw-Hill; 2016:(Ch) 14.</ref>
	*Most common in the summer and fall		*Most common in the summer and fall

Elcatracho: /* Background */

2021-01-15T07:00:09Z

Background

← Revisión anterior		Revisión del 07:00 15 ene 2021
Línea 6:		Línea 6:
	*Spread via the fecal-oral route<ref>Sobolewski B, Mittiga MR, Gonzalez del Rey JA. Pediatric conditions. In: Knoop KJ, Stack LB, Storrow AB, Thurman RJ, eds. The Atlas of Emergency Medicine. 4th ed. New York, NY: McGraw-Hill; 2016:(Ch) 14.</ref>		*Spread via the fecal-oral route<ref>Sobolewski B, Mittiga MR, Gonzalez del Rey JA. Pediatric conditions. In: Knoop KJ, Stack LB, Storrow AB, Thurman RJ, eds. The Atlas of Emergency Medicine. 4th ed. New York, NY: McGraw-Hill; 2016:(Ch) 14.</ref>
	*Most common in the summer and fall		*Most common in the summer and fall
			*Coxsackie A virus associated with [[herpangina]] and [[hand-foot-and-mouth disease]]
			*Coxsackie B virus associated with dilated [[cardiomyopathy]]

	==Differential Diagnosis==		==Differential Diagnosis==

Elcatracho: /* Clinical Features */

2021-01-15T06:55:16Z

Clinical Features

← Revisión anterior		Revisión del 06:55 15 ene 2021
Línea 3:		Línea 3:
	*Most common in the summer and fall		*Most common in the summer and fall

	==~~Clinical Features~~==		==Background==
	*~~Brief prodrome with [[Fever]]~~, ~~malaise~~, ~~[[upper respiratory infection]]~~, ~~lymphadenopathy~~		*Spread via the fecal-oral route<ref>Sobolewski B, Mittiga MR, Gonzalez del Rey JA. Pediatric conditions. In: Knoop KJ, Stack LB, Storrow AB, Thurman RJ, eds. The Atlas of Emergency Medicine. 4th ed. New York, NY: McGraw-Hill; 2016:(Ch) 14.</ref>
	*Common:		*Most common in the summer and fall
	**[[Herpangina]]: ~~painful oral vesicles with erythematous base which then ulcerate~~
	***Vesicles located in anterior oral cavity (~~most common on tongue and buccal mucosa~~)
	**[[Hand-foot-and-mouth disease]]: herpangina + red papules that become gray vesicles on hands and/~~or feet~~
	*~~Less~~ common:
	**[[Parotitis]]
	**[[Orchitis]]
	**Acute [[pericarditis]]
	**[[Myocarditis]]
	**[[Meningitis]], [[encephalitis]]
	**Some children get a desquamation of the ~~nails around 2 weeks afterwards (self resolves)~~

	==Differential Diagnosis==		==Differential Diagnosis==

Elcatracho: /* Background */

2021-01-15T06:54:42Z

Background

← Revisión anterior		Revisión del 06:54 15 ene 2021
Línea 1:		Línea 1:
	==Background==		==Background== <ref>Sobolewski B, Mittiga MR, Gonzalez del Rey JA. Pediatric conditions. In: Knoop KJ, Stack LB, Storrow AB, Thurman RJ, eds. The Atlas of Emergency Medicine. 4th ed. New York, NY: McGraw-Hill; 2016:(Ch) 14.</ref>
			*Spread via the fecal-oral route
			*Most common in the summer and fall

	==Clinical Features==		==Clinical Features==

Adamhaag: /* Clinical Features */

2017-08-20T17:49:16Z

Clinical Features

← Revisión anterior		Revisión del 17:49 20 ago 2017
Línea 5:		Línea 5:
	*Common:		*Common:
	**[[Herpangina]]: painful oral vesicles with erythematous base which then ulcerate		**[[Herpangina]]: painful oral vesicles with erythematous base which then ulcerate
			***Vesicles located in anterior oral cavity (most common on tongue and buccal mucosa)
	**[[Hand-foot-and-mouth disease]]: herpangina + red papules that become gray vesicles on hands and/or feet		**[[Hand-foot-and-mouth disease]]: herpangina + red papules that become gray vesicles on hands and/or feet
	*Less common:		*Less common:

Adamhaag: /* Disposition */

2017-08-20T17:47:42Z

Disposition

← Revisión anterior		Revisión del 17:47 20 ago 2017
Línea 29:		Línea 29:
	'''In infants, do NOT use oral lidocaine due to risk of lidocaine toxicity and FDA black box warning'''<ref>FDA recommends not using lidocaine to treat teething pain. http://www.fda.gov/Drugs/DrugSafety/ucm402240.htm</ref><ref>Curtis LA, Dolan TS, Seibert HE. Are one or two dangerous? Lidocaine and topical anesthetic exposures in children. J Emerg Med 2009;37:32-39</ref>		'''In infants, do NOT use oral lidocaine due to risk of lidocaine toxicity and FDA black box warning'''<ref>FDA recommends not using lidocaine to treat teething pain. http://www.fda.gov/Drugs/DrugSafety/ucm402240.htm</ref><ref>Curtis LA, Dolan TS, Seibert HE. Are one or two dangerous? Lidocaine and topical anesthetic exposures in children. J Emerg Med 2009;37:32-39</ref>
	==Disposition==		==Disposition==
			*Discharge with close outpatient followup to ensure adequate PO intake.

	==See Also==		==See Also==